Nevertheless, the difference in self-assessed pain between participants with and without obesity is mild and of uncertain clinical relevance, even if significant, and does not explain the higher CRP levels seen in participants with obesity at 24-week and 48-week follow-up. The gene discussed is CRP; the disease is obesity disorder.